MeSH D003218 - condylomata acuminata
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Imiquimod | Zartra | 1998-09-18 | |||
| Apotex | Imiquimod | Imiquimod | 2012-04-06 | |||
| Bausch Health Companies | Imiquimod | Aldara | 2024-04-01 | 1997-02-27 | ||
| Imiquimod | Zyclara | 2029-08-18 | 2010-03-25 | |||
| Cosette Pharmaceuticals | Imiquimod | Imiquimod | 2011-04-18 | |||
| Encube Ethicals | Imiquimod | Imiquimod | 2011-02-28 | |||
| Fougera Pharmaceuticals | Imiquimod | Imiquimod | 2010-02-25 | |||
| Glenmark Pharmaceuticals | Imiquimod | Imiquimod | 2012-03-06 | |||
| Padagis | Imiquimod | Imiquimod | 2010-09-07 | |||
| Strides Pharma Global | Imiquimod | Imiquimod | 2014-06-24 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
25%1/4
Phase 3
71%5/7
Approved: 3Overall Success rate: 12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use